| Original language | English (US) |
|---|---|
| Pages (from-to) | 3717-3719 |
| Number of pages | 3 |
| Journal | cancer |
| Volume | 127 |
| Issue number | 20 |
| DOIs | |
| State | Published - Oct 15 2021 |
Funding
Al B. Benson, III, reports support for attending meetings and/or travel from Array (Pfizer) and participation on a Data Safety Monitoring Board or Advisory Board for Bristol‐Myers Squibb, Merck, HalioDx, Abbvie, Janssen, Xencor, Astellas, SynCore, Apexigen, and Array (Pfizer), outside the submitted work. Ruth C. Carlos reports research support from the Neiman Health Policy Institute; salary support from the as editor in chief; travel and lodging support from an Association of University Radiologists GE Radiology Research Academic Fellowship, the Radiological Society of North America, the American Roentgen Ray Society, the Academy of Radiology, and Biomedical Imaging Research outside the submitted work. Journal of the American College of Radiology
Keywords
- (Alliance A15193)
- CALGB/SWOG 80405
- a secondary analysis
- by Rebecca Snyder et al
- racial differences in survival and response
- social determinants of health
- therapy in patients with metastatic colorectal cancer
ASJC Scopus subject areas
- Oncology
- Cancer Research
